Formulation Development Applications & Studies

  1. Cell Retention Technology And Specialized Cell Culture Media 8/11/2025

    Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.

  2. Simplifying Antibody-Drug Conjugate Payload Synthesis 8/5/2025

    ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.

  3. A Case Study Of The GLP-1 Receptor Agonist, Semaglutide, In Plasma 7/31/2025

    Light scattering reveals critical insights into the structural integrity, aggregation, and stability of GLP-1 analogs, which are essential for optimizing drug formulations and improving treatments.

  4. Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering 7/31/2025

    Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.

  5. Using SEC For Reliable Biotherapeutic Peptide Analysis 7/31/2025

    Discover a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable, high-resolution analysis.

  6. Complementing Routine Peptide Monitoring 7/29/2025

    Discover how to enhance your peptide analysis by integrating UV and mass spectral data into a single, streamlined workflow to boost data confidence and lab efficiency.

  7. LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting 7/29/2025

    Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.

  8. Characterization And Impurity Profiling Of Combined Amylin And GLP-1 Analogs 7/29/2025

    GLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics.

  9. Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS 7/29/2025

    Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.

  10. Development Of A High Sensitivity SPE-LC-MS/MS Assay 7/29/2025

    Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.